These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35792095)

  • 1. Renal Farnesoid X Receptor improves high fructose-induced salt-sensitive hypertension in mice by inhibiting DNM3 to promote nitro oxide production.
    Zhu Y; Tao Y; Wu C; Zeng Y; Du H; Xiang Q; Chen Y; Zhu Q; Wang L
    J Hypertens; 2022 Aug; 40(8):1577-1588. PubMed ID: 35792095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderation of gut microbiota and bile acid metabolism by chlorogenic acid improves high-fructose-induced salt-sensitive hypertension in mice.
    Zhu Q; Zhu Y; Liu Y; Tao Y; Lin Y; Lai S; Liang Z; Chen Y; Chen Y; Wang L
    Food Funct; 2022 Jul; 13(13):6987-6999. PubMed ID: 35708145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate (20%) fructose-enriched diet stimulates salt-sensitive hypertension with increased salt retention and decreased renal nitric oxide.
    Gordish KL; Kassem KM; Ortiz PA; Beierwaltes WH
    Physiol Rep; 2017 Apr; 5(7):. PubMed ID: 28408634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut dysbiosis contributes to high fructose-induced salt-sensitive hypertension in Sprague-Dawley rats.
    Chen Y; Zhu Y; Wu C; Lu A; Deng M; Yu H; Huang C; Wang W; Li C; Zhu Q; Wang L
    Nutrition; 2020; 75-76():110766. PubMed ID: 32305658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat.
    Yamaleyeva LM; Lindsey SH; Varagic J; Zhang LL; Gallagher PE; Chen AF; Chappell MC
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):529-38. PubMed ID: 22370956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoguanidine attenuates hypertension, whereas 7-nitroindazole exacerbates kidney damage in spontaneously hypertensive rats: the role of nitric oxide.
    Huang CF; Hsu CN; Chien SJ; Lin YJ; Huang LT; Tain YL
    Eur J Pharmacol; 2013 Jan; 699(1-3):233-40. PubMed ID: 23201071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
    Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
    Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-C attenuates renal damage in salt-sensitive hypertension.
    Beaini S; Saliba Y; Hajal J; Smayra V; Bakhos JJ; Joubran N; Chelala D; Fares N
    J Cell Physiol; 2019 Jun; 234(6):9616-9630. PubMed ID: 30378108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of salt loading on nitric oxide synthase expression in normotensive rats.
    Ni Z; Vaziri ND
    Am J Hypertens; 2001 Feb; 14(2):155-63. PubMed ID: 11243307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of farnesoid X receptor (FXR) induces crystallin zeta expression in mouse medullary collecting duct cells.
    Alam G; Luan Z; Gul A; Lu H; Zhou Y; Huo X; Li Y; Du C; Luo Z; Zhang H; Xu H; Zheng F; Guan Y; Zhang X
    Pflugers Arch; 2020 Nov; 472(11):1631-1641. PubMed ID: 32914211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress.
    Xu S; Huang S; Luan Z; Chen T; Wei Y; Xing M; Li Y; Du C; Wang B; Zheng F; Wang N; Guan Y; Gustafsson JÅ; Zhang X
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5600-5605. PubMed ID: 29739889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
    Wang XX; Jiang T; Shen Y; Caldas Y; Miyazaki-Anzai S; Santamaria H; Urbanek C; Solis N; Scherzer P; Lewis L; Gonzalez FJ; Adorini L; Pruzanski M; Kopp JB; Verlander JW; Levi M
    Diabetes; 2010 Nov; 59(11):2916-27. PubMed ID: 20699418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
    Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-fat, refined-carbohydrate diet affects renal NO synthase protein expression and salt sensitivity.
    Roberts CK; Vaziri ND; Sindhu RK; Barnard RJ
    J Appl Physiol (1985); 2003 Mar; 94(3):941-6. PubMed ID: 12433862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats.
    Nishimoto Y; Tomida T; Matsui H; Ito T; Okumura K
    Hypertension; 2002 Aug; 40(2):190-4. PubMed ID: 12154112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High salt intake induces collecting duct HDAC1-dependent NO signaling.
    Sedaka R; Hyndman KA; Mironova E; Stockand JD; Pollock JS
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F297-F307. PubMed ID: 33356953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesoid X receptor promotes renal ischaemia-reperfusion injury by inducing tubular epithelial cell apoptosis.
    Xu Y; Li D; Wu J; Zhang M; Shao X; Xu L; Tang L; Zhu M; Ni Z; Zhang M; Mou S
    Cell Prolif; 2021 Apr; 54(4):e13005. PubMed ID: 33594777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macula Densa Nitric Oxide Synthase 1β Protects against Salt-Sensitive Hypertension.
    Lu Y; Wei J; Stec DE; Roman RJ; Ge Y; Cheng L; Liu EY; Zhang J; Hansen PB; Fan F; Juncos LA; Wang L; Pollock J; Huang PL; Fu Y; Wang S; Liu R
    J Am Soc Nephrol; 2016 Aug; 27(8):2346-56. PubMed ID: 26647426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Rho GDP dissociation inhibitor α in control of epithelial sodium channel (ENaC)-mediated sodium reabsorption.
    Pavlov TS; Levchenko V; Staruschenko A
    J Biol Chem; 2014 Oct; 289(41):28651-9. PubMed ID: 25164814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
    Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
    Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.